Imperva, Inc. (IMPV) Receives $52.38 Average Price Target from Analysts

Imperva, Inc. (NASDAQ:IMPV) has been given a consensus rating of “Hold” by the twenty analysts that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $52.38.

IMPV has been the subject of several analyst reports. Evercore ISI set a $56.00 target price on Imperva and gave the stock a “buy” rating in a report on Thursday, August 10th. Monness Crespi & Hardt boosted their target price on Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Piper Jaffray Companies set a $58.00 target price on Imperva and gave the stock a “buy” rating in a report on Monday, August 28th. Royal Bank Of Canada restated a “buy” rating and issued a $49.00 target price on shares of Imperva in a report on Wednesday, October 18th. Finally, Oppenheimer Holdings, Inc. restated a “buy” rating and issued a $55.00 target price on shares of Imperva in a report on Thursday, November 9th.

COPYRIGHT VIOLATION WARNING: “Imperva, Inc. (IMPV) Receives $52.38 Average Price Target from Analysts” was originally posted by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/11/22/imperva-inc-impv-receives-52-38-average-price-target-from-analysts.html.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the transaction, the director now directly owns 99,598 shares of the company’s stock, valued at approximately $4,341,476.82. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 1.90% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Ameritas Investment Partners Inc. increased its position in shares of Imperva by 18.7% during the second quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after purchasing an additional 464 shares during the period. SG Americas Securities LLC bought a new stake in shares of Imperva during the third quarter valued at approximately $134,000. First Quadrant L P CA bought a new stake in shares of Imperva during the third quarter valued at approximately $136,000. Migdal Insurance & Financial Holdings Ltd. increased its position in shares of Imperva by 26.2% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after purchasing an additional 866 shares during the period. Finally, Amalgamated Bank bought a new stake in shares of Imperva during the second quarter valued at approximately $206,000. Institutional investors and hedge funds own 92.20% of the company’s stock.

Shares of Imperva (NASDAQ:IMPV) traded up $0.15 during trading on Friday, hitting $40.45. The stock had a trading volume of 235,700 shares, compared to its average volume of 441,399. Imperva has a fifty-two week low of $35.45 and a fifty-two week high of $52.40.

Imperva (NASDAQ:IMPV) last announced its quarterly earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.11. The business had revenue of $83.89 million during the quarter, compared to analyst estimates of $83.79 million. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. The firm’s revenue was up 22.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.08 EPS. sell-side analysts anticipate that Imperva will post -0.52 earnings per share for the current year.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

What are top analysts saying about Imperva Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Imperva Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit